137 related articles for article (PubMed ID: 18668352)
21. Long-term safety and efficacy of a chlorofluorocarbon-free beclomethasone dipropionate extrafine aerosol.
Fireman P; Prenner BM; Vincken W; Demedts M; Mol SJ; Cohen RM
Ann Allergy Asthma Immunol; 2001 May; 86(5):557-65. PubMed ID: 11379808
[TBL] [Abstract][Full Text] [Related]
22. A correlation equation for the mass median aerodynamic diameter of the aerosol emitted by solution metered dose inhalers.
Ivey JW; Lewis D; Church T; Finlay WH; Vehring R
Int J Pharm; 2014 Apr; 465(1-2):18-24. PubMed ID: 24524827
[TBL] [Abstract][Full Text] [Related]
23. Health-related quality of life in moderate asthma: 400 microg hydrofluoroalkane beclomethasone dipropionate vs 800 microg chlorofluorocarbon beclomethasone dipropionate. The Study Group.
Juniper EF; Buist AS
Chest; 1999 Nov; 116(5):1297-303. PubMed ID: 10559091
[TBL] [Abstract][Full Text] [Related]
24. Growth, systemic safety, and efficacy during 1 year of asthma treatment with different beclomethasone dipropionate formulations: an open-label, randomized comparison of extrafine and conventional aerosols in children.
Pedersen S; Warner J; Wahn U; Staab D; Le Bourgeois M; Van Essen-Zandvliet E; Arora S; Szefler SJ;
Pediatrics; 2002 Jun; 109(6):e92. PubMed ID: 12042586
[TBL] [Abstract][Full Text] [Related]
25. Acute safety of beclomethasone dipropionate in a new CFC-free propellant system in asthmatic patients.
Ayres JG; Simmons JL; Stampone P
Respir Med; 1999 Jan; 93(1):27-32. PubMed ID: 10464845
[TBL] [Abstract][Full Text] [Related]
26. Investigation into the influence of polymeric stabilizing excipients on inter-particulate forces in pressurised metered dose inhalers.
Traini D; Young PM; Rogueda P; Price R
Int J Pharm; 2006 Aug; 320(1-2):58-63. PubMed ID: 16735100
[TBL] [Abstract][Full Text] [Related]
27. Application of USP inlet extensions to the TSI impactor system 3306/3320 using HFA 227 based solution metered dose inhalers.
Mogalian E; Myrdal PB
Drug Dev Ind Pharm; 2005 Dec; 31(10):977-85. PubMed ID: 16316853
[TBL] [Abstract][Full Text] [Related]
28. Short-term growth and adrenal function in children with asthma treated with inhaled beclomethasone dipropionate hydrofluoroalkane-134a.
Wolthers OD
Pediatr Allergy Immunol; 2006 Dec; 17(8):613-9. PubMed ID: 17121590
[TBL] [Abstract][Full Text] [Related]
29. Effects of Formulation Variables on Lung Dosimetry of Albuterol Sulfate Suspension and Beclomethasone Dipropionate Solution Metered Dose Inhalers.
Schroeter JD; Sheth P; Hickey AJ; Asgharian B; Price OT; Holt JT; Conti DS; Saluja B
AAPS PharmSciTech; 2018 Jul; 19(5):2335-2345. PubMed ID: 29858973
[TBL] [Abstract][Full Text] [Related]
30. Crosslinked chitosan nanoparticle formulations for delivery from pressurized metered dose inhalers.
Sharma K; Somavarapu S; Colombani A; Govind N; Taylor KM
Eur J Pharm Biopharm; 2012 May; 81(1):74-81. PubMed ID: 22245573
[TBL] [Abstract][Full Text] [Related]
31. Step-down therapy with low-dose fluticasone-salmeterol combination or medium-dose hydrofluoroalkane 134a-beclomethasone alone.
Fowler SJ; Currie GP; Lipworth BJ
J Allergy Clin Immunol; 2002 Jun; 109(6):929-35. PubMed ID: 12063520
[TBL] [Abstract][Full Text] [Related]
32. Extra-fine corticosteroid aerosols from hydrofluoroalkane-134a metered-dose inhalers: potential advantages and disadvantages.
Tashkin DP
Chest; 1999 Feb; 115(2):316-8. PubMed ID: 10027423
[No Abstract] [Full Text] [Related]
33. Asthma control with extrafine-particle hydrofluoroalkane-beclometasone vs. large-particle chlorofluorocarbon-beclometasone: a real-world observational study.
Barnes N; Price D; Colice G; Chisholm A; Dorinsky P; Hillyer EV; Burden A; Lee AJ; Martin RJ; Roche N; von Ziegenweidt J; Israel E
Clin Exp Allergy; 2011 Nov; 41(11):1521-32. PubMed ID: 21752116
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and safety overview of a new inhaled corticosteroid, QVAR (hydrofluoroalkane-beclomethasone extrafine inhalation aerosol), in asthma.
Vanden Burgt JA; Busse WW; Martin RJ; Szefler SJ; Donnell D
J Allergy Clin Immunol; 2000 Dec; 106(6):1209-26. PubMed ID: 11112914
[TBL] [Abstract][Full Text] [Related]
35. A pilot study to assess lung deposition of HFA-beclomethasone and CFC-beclomethasone from a pressurized metered dose inhaler with and without add-on spacers and using varying breathhold times.
Leach CL; Colice GL
J Aerosol Med Pulm Drug Deliv; 2010 Dec; 23(6):355-61. PubMed ID: 20575669
[TBL] [Abstract][Full Text] [Related]
36. An assessment of beclomethasone dipropionate clathrate formation in a model suspension metered dose inhaler.
Bouhroum A; Burley JC; Champness NR; Toon RC; Jinks PA; Williams PM; Roberts CJ
Int J Pharm; 2010 May; 391(1-2):98-106. PubMed ID: 20184946
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics of beclomethasone 17-monopropionate from a beclomethasone dipropionate extrafine aerosol in adults with asthma.
Harrison LI; Kurup S; Wagner C; Ekholm BP; Larson JS; Kaiser HB
Eur J Clin Pharmacol; 2002 Jun; 58(3):197-201. PubMed ID: 12107606
[TBL] [Abstract][Full Text] [Related]
38. Improved airway targeting with the CFC-free HFA-beclomethasone metered-dose inhaler compared with CFC-beclomethasone.
Leach CL; Davidson PJ; Boudreau RJ
Eur Respir J; 1998 Dec; 12(6):1346-53. PubMed ID: 9877489
[TBL] [Abstract][Full Text] [Related]
39. Esophageal candidiasis as a side effect of inhaled fluticasone propionate dry powder: recovery by switching over to hydrofluoroalkane-134a beclomethasone dipropionate (HFA-BDP).
Kobayashi Y; Yasuba H; Kudou M; Hamada K; Kita H
Int J Clin Pharmacol Ther; 2006 May; 44(5):193-7. PubMed ID: 16724573
[TBL] [Abstract][Full Text] [Related]
40. Effects of HFA- and CFC-beclomethasone dipropionate on the bronchial response to methacholine (MCh) in mild asthma.
Micheletto C; Guerriero M; Tognella S; Dal Negro RW
Respir Med; 2005 Jul; 99(7):850-5. PubMed ID: 15939246
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]